Skip to content

Clinical study of sympathetic denervation of renal artery adventitia in the treatment of refractory hypertension

Clinical study of sympathetic denervation of renal artery adventitia in the treatment of refractory hypertension

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073107
Enrollment
Unknown
Registered
2023-07-01
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

resistant hypertension

Interventions

Group 1:laparoscopic sympathetic denervation of bilateral renal artery adventitia
Group 2:laparoscopic sympathetic denervation of unilateral renal artery adventitia

Sponsors

the Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: a. Clinically diagnosed as refractory hypertension; b. Renal artery diameter >=4mm and length >=20mm; c. Age >=18 years old and <=75 years old; d. The patient voluntarily participated in and signed the informed consent, and cooperated with the later follow-up.

Exclusion criteria

Exclusion criteria: a. Renal artery abnormalities: CTA or DSA examination showed mechanical stenosis of either renal artery; Former renal arterioplasty or stent implantation; There were branches in either renal artery and the main artery supplied < 75% of the kidney; Anatomic abnormalities that were evaluated as difficult to insert ablation electrodes; b. Factors of cardiovascular and cerebrovascular instability: myocardial infarction, unstable angina pectoris or cerebrovascular disease occurred within 6 months; c. The patient has other serious organic diseases; d. Patients who participated in other clinical trials within three months prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Level of blood pressure;Renin/aldosterone;

Countries

China

Contacts

Public ContactBoxin Xue

the Second Affiliated Hospital of Soochow University

xbxurol@163.com+86 512 6778 4139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026